CHRISTEN CARTER: Open Payments
NPI 1982378683 · COVINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 29 payments from 6 companies in 2025. Trend: 2023 $212 · 2024 $289 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $217 |
| ABBVIE INC. | 4 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
Products named: ARISTADA, VRAYLAR, INGREZZA, HETLIOZ, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
